Led by Helmholtz Munich, scientists have developed an accessible software solution specifically designed for the analysis of complex medical health data.
Danish company pays $145M upfront to license nasal spray alternative to EpiPen
A Danish company is spending $145 million upfront for certain rights to the first-ever needle-free adrenaline nasal spray for severe allergic reactions, unlocking sales potential